Abstract. To elucidate the role of prolactin (Prl) in the endocrinology of early human pregnancy, 28 healthy women were given 5.0\p=n-\7.5 mg of bromocriptine daily for two weeks between weeks 6\p=n-\9 of normal gestation. Plasma Prl, oestradiol-17\g=b\(Oe2), progesterone (P), testosterone (T) and human placental lactogen (hPL) 
measured before, and one and two weeks after the start of bromocriptine, and they were compared with those in 22 control women who were followed similarly but without bromocriptine treatment. Bromocriptine treatment induced a significant Prl depression at one week (7.3 \ m=+-\ 4.3 ng/ml vs 23.7 \m=+-\11.4 ng/ml) and two weeks (5.3 \m=+-\2.5 ng/ml vs 31.9 \m=+-\ 16.4 ng/ml). Oe2, P. T and hPL levels, however, showed no significant differences between the groups. Two women undergoing bromocriptine treatment (7.1%) and one control woman (4.5%) experienced spontaneous incomplete abortion during the study pe- riod, but these three already had a low Oe2 level and a low/or undetectable hPL level at the beginning of the study. It (Barberia et al. 1975 ), yet it is not known whether this Prl rise is crucial for the normal progress of earlv pregnancy and for the normal production of sex steroids and peptide hormones. The present study was therefore designed to deter¬ mine the effects of bromocriptine on the plasma levels of prolactin, oestradiol, progesterone, testos¬ terone and human placental lactogen during early human pregnancy.
Materials and Methods
Fifty healthy women admitted for legal abortion between weeks 6 -9 of gestation volunteered for this study after being fully informed about its purpose and course (Table  I ). The pregnancies were uncomplicated, with the uter¬ ine sizes comparable with the duration of amenorrhoea. Twenty-eight women were given bromocriptine (Par- (Hammond et al. 1977a ). Oestradiol-17ß
(Oe2), progesterone (P) and testosterone (T) were deter¬ mined by radioimmunoassays using iodinated ligands (Hammond et al. 1977b 
Results

Hormonal findings
Before the start of the trial, mean hormonal con¬ centrations were similar in both groups (Table 2) .
Bromocriptine significantly lowered (P < 0.001) the individual and mean Prl levels at one and two weeks. The mean Oe2, P, T and hPL levels did not differ between the groups either at one or two weeks of the trial (Table 2) . (Schulz et al. 1976 (Schulz et al. , 1978 , and compared with that, Prl suppres¬ sion in our studv was not so marked. (Turkington 1972) and with a report of normal Prl levels in women with subsequent abor¬ tion (Ylikorkala et al. 1979) . In some other studies however Prl level was initially low, and fell before abortion (Schmidt-Gollwitzer & Saxena 1975; Jovanovic etal. 1978 ).
There appears to be three phases of P produc¬ tion in earlv pregnancy (Yoshimi et al. 1969; Tulchinsky & Hobel 1973; Mishell et al. 1973) . At first, all the P comes from the ovaries, and this period probably does not last bevond weeks 5 or 6 of gestation. There is then a period extending to weeks 10-12 when both the ovaries and trophablast contribute to the total production, and finally, the placenta becomes the dominant P source. The Oe2 patterns resemble those of P (Tulchinsky 8c Hobel 1973; Mishell et al. 1973 ). Circulating T levels also rise in early pregnancy, partly due to the foeto-placental contribution (Gandy 1976) . In our studv, the samples during bromocriptine intake were taken on average at 8.7 ±1.1 (mean ± sn) and 9.7 ±1.1 weeks of gestation, when the Oe2 and P production was gradually shifting from the cor¬ pus luteum to the foeto-placental unit. Apart from a significant Prl suppression, Oe2, P. T and hPL levels were similar in the bromocriptine and con¬ trol groups. This suggests that neither maternal 'hvpoprolactinaemia' nor bromocriptine interfere with the normal synthesis of sex steroids bv the corpus luteum and/or foeto-placental unit during earlv human gestation.
